VIVOTEK Ranks 14th in 2024 Security 50

2024-12-18 VIVOTEK Inc. HaiPress

TAIPEI,Dec. 12,2024 -- VIVOTEK (3454-TW),the global leading security solution provider,continues to demonstrate exceptional capabilities by securing the 14th spot in the 2024 Security 50,remaining the only Taiwanese company in the top 20. This marks the company's 12th consecutive year in this prestigious ranking.


VIVOTEK showcases its expertise in the security industry and has been increasingly committed to sustainable development in recent years. Through innovative technologies,it creates value and impact in the field of security.

The Security 50,organized by a&s magazine (asmag.com),is one of the most respected rankings in the security industry. Since 2003,it has evaluated global leaders based on rigorous financial analysis,providing key insights for industry professionals and investors.

As it approaches its 25th anniversary,VIVOTEK continues to lead with AI-powered cameras,intelligent video management,and cloud services,leveraging its Taiwan-based R&D and manufacturing strengths to deliver a comprehensive security ecosystem amid growing demand for smart city and AI security solutions.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map